与死亡率相关的危险因素:勃兰登堡州心内膜炎登记结果。

IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Thoracic and Cardiovascular Surgeon Pub Date : 2024-02-09 DOI:10.1055/a-2199-2344
Roya Ostovar, Filip Schroeter, Frarzane Seifi Zinab, Dirk Fritzsche, Hans-Heinrich Minden, Nirmeen Lasheen, Martin Hartrumpf, Oliver Ritter, Gesine Dörr, Johannes Maximilian Albes
{"title":"与死亡率相关的危险因素:勃兰登堡州心内膜炎登记结果。","authors":"Roya Ostovar, Filip Schroeter, Frarzane Seifi Zinab, Dirk Fritzsche, Hans-Heinrich Minden, Nirmeen Lasheen, Martin Hartrumpf, Oliver Ritter, Gesine Dörr, Johannes Maximilian Albes","doi":"10.1055/a-2199-2344","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong> Endocarditis as a potentially life-threatening disease with high complication and mortality rates. In recent years, an increase in the incident of endocarditis has been reported throughout Europe. In the aging society, successful treatment is complex and challenging owing to the high rate of multimorbidity.</p><p><strong>Methods: </strong> We initiated a statewide prospective multicenter endocarditis registry in 2020. Perioperative risk factors, comorbidities, microbiological, laboratory and imaging diagnostics, complications, and mortality including 1-year follow-up were collected. The present midterm analysis includes factors influencing mortality in the first 313 patients.</p><p><strong>Result: </strong> In-hospital mortality and 1-year mortality were 28.4 and 40.9%, respectively. Preoperative risk factors include age (<i>p</i> < 0.001), EuroSCORE II (<i>p</i> < 0.001), coronary artery disease (<i>p</i> = 0.022), pacemaker probe infection (<i>p</i> = 0.033), preoperative left ventricular ejection fraction (LVEF), systemic inflammatory response syndrome (SIRS), pulmonary edema, heart failure, septic emboli, acute renal failure, impaired coagulation, hypalbuminemia (<i>p</i> < 0.001), and N-terminal prohormone of brain natriuretic peptide (NTproBNP) (<i>p</i> = 0.001). The presence of peri-annular abscess, perforation, and shunt were associated with increased mortality (<i>p</i> = 0.004, 0.001, and 0.004, respectively). In addition, cardiopulmonary bypass time influenced mortality (<i>p</i> = 0.002). The main postoperative causes of death were multi-organ failure, renal failure, vasoplegia, and low-output syndrome (<i>p</i> < 0.001). Previous endocarditis was 7.7%, while 35.5% were prosthetic valve recipients and 33.6% were redo surgeries.</p><p><strong>Conclusion: </strong> Our first registry data show the complexity of endocarditis patients and the challenging treatment. Some risk factors can be treated preoperatively. For instance, hypalbuminemia and the duration of the procedure can be controlled with adequate albumin substitution and carefully planned procedures restricted to the essential requirements, that is, hybrid approaches with consecutive interventions.</p>","PeriodicalId":23057,"journal":{"name":"Thoracic and Cardiovascular Surgeon","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Insights into Mortality-Related Risk Factors in Infective Endocarditis: Results from the Brandenburg State Endocarditis Register.\",\"authors\":\"Roya Ostovar, Filip Schroeter, Frarzane Seifi Zinab, Dirk Fritzsche, Hans-Heinrich Minden, Nirmeen Lasheen, Martin Hartrumpf, Oliver Ritter, Gesine Dörr, Johannes Maximilian Albes\",\"doi\":\"10.1055/a-2199-2344\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong> Endocarditis as a potentially life-threatening disease with high complication and mortality rates. In recent years, an increase in the incident of endocarditis has been reported throughout Europe. In the aging society, successful treatment is complex and challenging owing to the high rate of multimorbidity.</p><p><strong>Methods: </strong> We initiated a statewide prospective multicenter endocarditis registry in 2020. Perioperative risk factors, comorbidities, microbiological, laboratory and imaging diagnostics, complications, and mortality including 1-year follow-up were collected. The present midterm analysis includes factors influencing mortality in the first 313 patients.</p><p><strong>Result: </strong> In-hospital mortality and 1-year mortality were 28.4 and 40.9%, respectively. Preoperative risk factors include age (<i>p</i> < 0.001), EuroSCORE II (<i>p</i> < 0.001), coronary artery disease (<i>p</i> = 0.022), pacemaker probe infection (<i>p</i> = 0.033), preoperative left ventricular ejection fraction (LVEF), systemic inflammatory response syndrome (SIRS), pulmonary edema, heart failure, septic emboli, acute renal failure, impaired coagulation, hypalbuminemia (<i>p</i> < 0.001), and N-terminal prohormone of brain natriuretic peptide (NTproBNP) (<i>p</i> = 0.001). The presence of peri-annular abscess, perforation, and shunt were associated with increased mortality (<i>p</i> = 0.004, 0.001, and 0.004, respectively). In addition, cardiopulmonary bypass time influenced mortality (<i>p</i> = 0.002). The main postoperative causes of death were multi-organ failure, renal failure, vasoplegia, and low-output syndrome (<i>p</i> < 0.001). Previous endocarditis was 7.7%, while 35.5% were prosthetic valve recipients and 33.6% were redo surgeries.</p><p><strong>Conclusion: </strong> Our first registry data show the complexity of endocarditis patients and the challenging treatment. Some risk factors can be treated preoperatively. For instance, hypalbuminemia and the duration of the procedure can be controlled with adequate albumin substitution and carefully planned procedures restricted to the essential requirements, that is, hybrid approaches with consecutive interventions.</p>\",\"PeriodicalId\":23057,\"journal\":{\"name\":\"Thoracic and Cardiovascular Surgeon\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-02-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Thoracic and Cardiovascular Surgeon\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2199-2344\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thoracic and Cardiovascular Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2199-2344","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

目的:心内膜炎是一种潜在的危及生命的疾病,并发症和死亡率很高。近年来,整个欧洲都有增长的报告。在老龄化社会,由于多发病率高,成功的治疗是复杂和具有挑战性的。方法:我们于2020年启动了一项全州前瞻性多中心心内膜炎登记。收集围手术期危险因素、合并症、微生物学、实验室和影像学诊断、并发症和死亡率,包括1年随访。目前的中期分析包括影响前313名患者死亡率的因素。结果:住院死亡率和1年死亡率分别为28.4%和40.9%。术前风险因素,如年龄结论:我们的首次登记数据显示心内膜炎患者的复杂性和具有挑战性的治疗。一些危险因素可以在术前进行治疗。例如,高白蛋白血症和手术的持续时间可以通过适当的白蛋白替代和严格计划的手术来控制,这些手术仅限于基本要求,即具有连续干预的混合方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
New Insights into Mortality-Related Risk Factors in Infective Endocarditis: Results from the Brandenburg State Endocarditis Register.

Objective:  Endocarditis as a potentially life-threatening disease with high complication and mortality rates. In recent years, an increase in the incident of endocarditis has been reported throughout Europe. In the aging society, successful treatment is complex and challenging owing to the high rate of multimorbidity.

Methods:  We initiated a statewide prospective multicenter endocarditis registry in 2020. Perioperative risk factors, comorbidities, microbiological, laboratory and imaging diagnostics, complications, and mortality including 1-year follow-up were collected. The present midterm analysis includes factors influencing mortality in the first 313 patients.

Result:  In-hospital mortality and 1-year mortality were 28.4 and 40.9%, respectively. Preoperative risk factors include age (p < 0.001), EuroSCORE II (p < 0.001), coronary artery disease (p = 0.022), pacemaker probe infection (p = 0.033), preoperative left ventricular ejection fraction (LVEF), systemic inflammatory response syndrome (SIRS), pulmonary edema, heart failure, septic emboli, acute renal failure, impaired coagulation, hypalbuminemia (p < 0.001), and N-terminal prohormone of brain natriuretic peptide (NTproBNP) (p = 0.001). The presence of peri-annular abscess, perforation, and shunt were associated with increased mortality (p = 0.004, 0.001, and 0.004, respectively). In addition, cardiopulmonary bypass time influenced mortality (p = 0.002). The main postoperative causes of death were multi-organ failure, renal failure, vasoplegia, and low-output syndrome (p < 0.001). Previous endocarditis was 7.7%, while 35.5% were prosthetic valve recipients and 33.6% were redo surgeries.

Conclusion:  Our first registry data show the complexity of endocarditis patients and the challenging treatment. Some risk factors can be treated preoperatively. For instance, hypalbuminemia and the duration of the procedure can be controlled with adequate albumin substitution and carefully planned procedures restricted to the essential requirements, that is, hybrid approaches with consecutive interventions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.40
自引率
6.70%
发文量
365
审稿时长
3 months
期刊介绍: The Thoracic and Cardiovascular Surgeon publishes articles of the highest standard from internationally recognized thoracic and cardiovascular surgeons, cardiologists, anesthesiologists, physiologists, and pathologists. This journal is an essential resource for anyone working in this field. Original articles, short communications, reviews and important meeting announcements keep you abreast of key clinical advances, as well as providing the theoretical background of cardiovascular and thoracic surgery. Case reports are published in our Open Access companion journal The Thoracic and Cardiovascular Surgeon Reports.
期刊最新文献
HTK solution cardioplegia in paediatric patients: a meta-analysis. Intraoperative Invasive Coronary Angiography after Coronary Artery Bypass Grafting. Distal Events Following Emergent Operation for DeBakey Type I Aortic Dissection. Lactate Dehydrogenase Levels after aortic valve replacement: What do they tell us? Impact of High-Intensity Statin on Atrial Fibrillation After Off-Pump Coronary Artery Bypass.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1